Article: Effects of somatostatin, octreotide and pitressin plus nitroglycerine on systemic and portal haemodynamics in the control of acute variceal bleeding

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleEffects of somatostatin, octreotide and pitressin plus nitroglycerine on systemic and portal haemodynamics in the control of acute variceal bleeding
AuthorsZhang, HB1
Wong, BCY1
Zhou, XM1
Guo, XG1
Zhao, SJ1
Wang, JH1
Wu, KC1
Ding, J1
Lam, SK1
Fan, DM1
Issue Date2002
PublisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/IJCP
CitationInternational Journal Of Clinical Practice, 2002, v. 56 n. 6, p. 447-451 [How to Cite?]
AbstractTo examine the haemodynamic effects of somatostatin (SS) and octreotide (OC) versus pitressin plus nitroglycerine (PN) in the control of variceal bleeding, 224 patients with acute oesophageal and gastric variceal haemorrhage were randomly divided into three groups and treated with SS, OC and PN; they also had their Doppler ultrasound parameters measured before, during and after treatment. The success rates of bleeding control in the SS (80.9%, 86.8% and 89.7%, p < 0.001) and OC (75.3%, 80.8% and 84.9%, p < 0.01) groups were significantly higher than in the PN group (51.8%, 59.0% and 65.1 %) at 24, 48 and 72 hours respectively, and the average duration of SS (12.7 + 6.8 h) And OC (13.8 + 8.0 h) was significantly lower than that of PN (24.6 + 15.4 h, p < 0.001). Side-effects of SS (7.4%) and OC (8.2%) were less than those of PN (41.0%, p < 0.001 and p < 0.01). The diameter of portal vein (PVD), velocity of portal vein (PVV), volume of portal blood flow (PVF) and hepatic artery pulsatility index (HA-PI) in all three groups decreased significantly during initial treatment, but recovered when treatment was stopped. Heart rate and cardiac output decreased significantly in patients treated with SS and OC; mean arterial pressure was unchanged. However, heart rate and mean arterial pressure increased, and cardiac output decreased, with PN. Somatostatin and octreotide were more effective than pitressin plus nitroglycerine in patients with acute variceal haemorrhage, with fewer side-effects, and may decrease PVF and portal vein pressure through reduction of cardiac output and dilatation of the visceral blood vessels.
ISSN1368-5031
2011 Impact Factor: 2.415
2011 SCImago Journal Rankings: 0.162
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorZhang, HB
dc.contributor.authorWong, BCY
dc.contributor.authorZhou, XM
dc.contributor.authorGuo, XG
dc.contributor.authorZhao, SJ
dc.contributor.authorWang, JH
dc.contributor.authorWu, KC
dc.contributor.authorDing, J
dc.contributor.authorLam, SK
dc.contributor.authorFan, DM
dc.date.accessioned2012-09-05T05:21:36Z
dc.date.available2012-09-05T05:21:36Z
dc.date.issued2002
dc.description.abstractTo examine the haemodynamic effects of somatostatin (SS) and octreotide (OC) versus pitressin plus nitroglycerine (PN) in the control of variceal bleeding, 224 patients with acute oesophageal and gastric variceal haemorrhage were randomly divided into three groups and treated with SS, OC and PN; they also had their Doppler ultrasound parameters measured before, during and after treatment. The success rates of bleeding control in the SS (80.9%, 86.8% and 89.7%, p < 0.001) and OC (75.3%, 80.8% and 84.9%, p < 0.01) groups were significantly higher than in the PN group (51.8%, 59.0% and 65.1 %) at 24, 48 and 72 hours respectively, and the average duration of SS (12.7 + 6.8 h) And OC (13.8 + 8.0 h) was significantly lower than that of PN (24.6 + 15.4 h, p < 0.001). Side-effects of SS (7.4%) and OC (8.2%) were less than those of PN (41.0%, p < 0.001 and p < 0.01). The diameter of portal vein (PVD), velocity of portal vein (PVV), volume of portal blood flow (PVF) and hepatic artery pulsatility index (HA-PI) in all three groups decreased significantly during initial treatment, but recovered when treatment was stopped. Heart rate and cardiac output decreased significantly in patients treated with SS and OC; mean arterial pressure was unchanged. However, heart rate and mean arterial pressure increased, and cardiac output decreased, with PN. Somatostatin and octreotide were more effective than pitressin plus nitroglycerine in patients with acute variceal haemorrhage, with fewer side-effects, and may decrease PVF and portal vein pressure through reduction of cardiac output and dilatation of the visceral blood vessels.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationInternational Journal Of Clinical Practice, 2002, v. 56 n. 6, p. 447-451 [How to Cite?]
dc.identifier.epage451
dc.identifier.issn1368-5031
2011 Impact Factor: 2.415
2011 SCImago Journal Rankings: 0.162
dc.identifier.issue6
dc.identifier.pmid12166543
dc.identifier.scopuseid_2-s2.0-0036332450
dc.identifier.spage447
dc.identifier.urihttp://hdl.handle.net/10722/162605
dc.identifier.volume56
dc.languageeng
dc.publisherBlackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/IJCP
dc.publisher.placeUnited Kingdom
dc.relation.ispartofInternational Journal of Clinical Practice
dc.relation.referencesReferences in Scopus
dc.subject.meshAcute Disease
dc.subject.meshArginine Vasopressin - Therapeutic Use
dc.subject.meshDrug Therapy, Combination
dc.subject.meshEsophageal And Gastric Varices - Drug Therapy - Physiopathology - Ultrasonography
dc.subject.meshFemale
dc.subject.meshGastrointestinal Hemorrhage - Drug Therapy - Physiopathology - Ultrasonography
dc.subject.meshHemodynamics - Drug Effects
dc.subject.meshHepatic Artery - Ultrasonography
dc.subject.meshHumans
dc.subject.meshLiver Cirrhosis - Complications - Physiopathology - Ultrasonography
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNitroglycerin - Therapeutic Use
dc.subject.meshOctreotide - Therapeutic Use
dc.subject.meshPortal System - Physiopathology
dc.subject.meshPortal Vein - Ultrasonography
dc.subject.meshRegression Analysis
dc.subject.meshSomatostatin - Therapeutic Use
dc.subject.meshVasoconstrictor Agents - Therapeutic Use
dc.subject.meshVasodilator Agents - Therapeutic Use
dc.titleEffects of somatostatin, octreotide and pitressin plus nitroglycerine on systemic and portal haemodynamics in the control of acute variceal bleeding
dc.typeArticle
Author Affiliations
  1. Xijing Hospital